| 注册
首页|期刊导航|中国肿瘤生物治疗杂志|乙酰化修饰在甲状腺癌发生发展中的作用及其潜在的临床应用价值

乙酰化修饰在甲状腺癌发生发展中的作用及其潜在的临床应用价值

梁楠 敖倩 孙辉

中国肿瘤生物治疗杂志2025,Vol.32Issue(1):30-37,8.
中国肿瘤生物治疗杂志2025,Vol.32Issue(1):30-37,8.DOI:10.3872/j.issn.1007-385x.2025.01.005

乙酰化修饰在甲状腺癌发生发展中的作用及其潜在的临床应用价值

Role of acetylation modification in the occurrence and development of thyroid cancer and its potential clinical application value

梁楠 1敖倩 1孙辉1

作者信息

  • 1. 吉林大学中日联谊医院 甲状腺外科,吉林省外科转化医学重点实验室,吉林省甲状腺疾病防治工程实验室,吉林 长春 130000
  • 折叠

摘要

Abstract

Thyroid cancer is the most prevalent malignant tumor of the endocrine system,and its incidence has shown a significant upward trend in recent years.Acetylation,an important post-translational protein modification,is involved in regulating gene transcription,cell cycle progression,and invasion ability in various types of thyroid cancers.Additionally,histone deacetylase(HDAC)inhibitors have shown potential in the treatment of thyroid cancer.This article systematically reviews the biological functions and regulatory mechanisms of acetylation in the development and progression of thyroid cancer based on recent literature.Furthermore,it discusses the clinical application prospects of HDAC inhibitors,providing a solid theoretical basis and feasible therapeutic strategies for targeted therapy of thyroid cancer.

关键词

甲状腺癌/乙酰化修饰/组蛋白去乙酰化酶抑制剂/靶向治疗

Key words

thyroid cancer/acetylation modification/histone deacetylase(HDAC)inhibitor/targeted therapy

分类

医药卫生

引用本文复制引用

梁楠,敖倩,孙辉..乙酰化修饰在甲状腺癌发生发展中的作用及其潜在的临床应用价值[J].中国肿瘤生物治疗杂志,2025,32(1):30-37,8.

基金项目

吉林省自然科学基金(No.YDZJ202201ZYTS112) (No.YDZJ202201ZYTS112)

中国肿瘤生物治疗杂志

OA北大核心

1007-385X

访问量0
|
下载量0
段落导航相关论文